跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APIXABAN OLPHA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
APIXABAN OLPHA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
APIXABAN OLPHA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Olpha As
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 6, 2024
Approval ID
6ef46a0b3dae8a1e
Company
Olpha As
Type
Standard
Approval Details
Approval Id
6ef46a0b3dae8a1e
Drug Cima Aemps Name
APIXABAN OLPHA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
89868
Holder Company Name
Olpha As
Marketing Company Name
Olpha As
Authorization Date
2024-11-06
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
2,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Olpha As
Active Ingredients
APIXABAN
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 6, 2024
Approval ID
6ef46a0b3dae8a1e
Type
Standard
Back to CIMA-AEMPS Approvals